TuisEKSO • NASDAQ
add
Ekso Bionics Holdings Inc
Vorige sluiting
$0,72
Dagwisseling
$0,67 - $0,74
Jaarwisseling
$0,67 - $3,13
Markkapitalisasie
15,20 m USD
Gemiddelde volume
90,14 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | 4,13 m | -10,38% |
Bedryfskoste | 4,85 m | -10,01% |
Netto inkomste | -2,07 m | 38,42% |
Netto winsgrens | -50,18 | 31,30% |
Wins per aandeel | — | — |
EBITDA | -2,23 m | 10,97% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 8,29 m | -16,55% |
Totale bates | 29,21 m | -6,33% |
Totale aanspreeklikheid | 14,34 m | -9,96% |
Totale ekwiteit | 14,87 m | — |
Uitstaande aandele | 22,00 m | — |
Prys om te bespreek | 1,06 | — |
Opbrengs op bates | -23,48% | — |
Opbrengs op kapitaal | -33,02% | — |
Kontantvloei
Netto kontantverandering
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | -2,07 m | 38,42% |
Kontant van bedrywe | -2,28 m | 32,09% |
Kontant van beleggings | -8,00 k | 52,94% |
Kontant van finansiering | 4,69 m | — |
Netto kontantverandering | 2,41 m | 171,42% |
Beskikbare kontantvloei | -1,11 m | 57,80% |
Meer oor
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.
Ekso Bionics currently focuses in the health and industrial sectors.
The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
HUB
Gestig
2005
Webwerf
Werknemers
70